张培彤教授治疗化疗期原发性肺癌患者的临床经验  

Clinical Eexperience in the Treatment of Primary Lung Cancer Patients During Chemotherapy of Professor Zhang Peitong

作　　者：贺忠宁 张培彤[1] HE Zhongning;ZHANG Peitong(Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China;Beijing University of Chinese Medicine,Beijing 100029,China)

机构地区：[1]中国中医科学院广安门医院,北京100053 [2]北京中医药大学,北京100029

出　　处：《湖南中医药大学学报》2021年第2期200-204,共5页Journal of Hunan University of Chinese Medicine

基　　金：国家自然科学基金面上项目(81673797)。

摘　　要：原发性肺癌发病率高、生存期短、治疗难度大。张培彤教授从事肿瘤临床工作30余年,积累了大量临床经验,本文整理并分析了张培彤教授治疗化疗期原发性肺癌的临床经验。张培彤教授认为积聚病本就存在正气亏虚、癌毒内陷,加之化疗作为外来“毒邪”侵袭,加重了患者正气虚损,导致气血亏虚、脾肾失养。因此,原发性肺癌患者化疗期间的临床治疗思路重在益气养血、健脾益肾、祛瘀化痰、减毒增敏。张教授在此治则基础上灵活用药,随证化裁,获得显著临床疗效。The incidence of primary lung cancer is high,the survival time is short,the treatment is difficult.Professor Zhang Peitong has been engaged in clinical work of cancer for more than 30 years and has accumulated a great deal of clinical experience.This article sorted out and analyzed professor Zhang Peitong's clinical experience in treating primary lung cancer in chemotherapy stage.Professor Zhang Peitong believes that the accumulation disease exists deficiency of vital qi,cancer toxin invagination,plus chemotherapy as a foreign"toxin"invasion,aggravates the patient's deficiency of vital qi,leading to deficiency of vital qi and blood,dystrophy of spleen and kidney.Therefore,the clinical treatment of patients with primary lung cancer during chemotherapy is focused on invigorating qi and nourishing blood,invigorating spleen and kidney,removing blood stasis and resolving phlegm,reducing toxicity and increasing sensitization.On the basis of this therapeutic principle,professor Zhang applied drugs flexibly and made treatment according to the syndrome,and obtained significant clinical curative effect.

关 键 词：原发性肺癌 化疗 益气养血 健脾益肾 张培彤 

分 类 号：R273[医药卫生—中西医结合]